1,194
Views
120
CrossRef citations to date
0
Altmetric
Reviews

Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century

, &
Pages 451-464 | Received 13 Oct 2015, Accepted 26 Nov 2015, Published online: 19 Dec 2015

References

  • Kerns EH. High throughput physicochemical profiling for drug discovery. J Pharm Sci. 2001;90(11):1838–1858.
  • Serajuddin AT. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88(10):1058–1066.
  • Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech. 2015. DOI:10.1208/s12249-015-0360-7.
  • Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971;60(9):1281–1302.
  • Nikghalb LA, Singh G, Singh G, et al. Solid dispersion: methods and polymers to increase the solubility of poorly soluble drugs. J Appl Pharm Sci. 2012;2(10):170–175.
  • Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm. 2002;54(2):107–117.
  • Kolter K, Karl M, Gryczke A. Ludwigshafen am Rhein B. Hot-melt extrusion with BASF pharma polymers: extrusion compendium. Ludwigshafen: BASF; 2012. p. 1–192.
  • Lang B, McGinity JW, Williams RO 3rd. Hot-melt extrusion-basic principles and pharmaceutical applications. Drug Dev Ind Pharm. 2014;40(9):1133–1155.
  • Shah S, Repka MA. Melt extrusion in drug delivery: three decades of progress. In: Repka MA, Langley N, DiNunzio J, editors. Melt extrusion. New York (NY): Springer; 2013. p. 3–46.
  • Stankovic M, Frijlink HW, Hinrichs WL. Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization. Drug Discov Today. 2015;20(7):812–823.
  • Klein CE, Chiu YL, Awni W, et al. The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect. J Acquir Immune Defic Syndr. 2007;44(4):401–410.
  • Law D, Krill SL, Schmitt EA, et al. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. J Pharm Sci. 2001;90(8):1015–1025.
  • Maniruzzaman M, Boateng JS, Snowden MJ, et al. A review of hot-melt extrusion: process technology to pharmaceutical products. ISRN Pharm. 2012;2012:436763.
  • Van Laarhoven JA, Kruft MA, Vromans H. In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring. Int J Pharm. 2002;232(1–2):163–173.
  • Vo CL, Park C, Lee BJ. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm. 2013;85(3 Pt B):799–813.
  • Gryczke A, Schminke S, Maniruzzaman M, et al. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion. Colloids Surf B Biointerfaces. 2011;86(2):275–284.
  • Baert LEC, Verreck G, Thoné D Antifungal compositions with improved bioavailability. US20030082239 A1. 2003.
  • DiNunzio JC, Zhang F, Martin C, et al. Melt extrusion. In: Williams III RO, Watts AB, Miller DA, editors. Formulating poorly water soluble drugs. New York (NY): Springer; 2012. p. 311–362.
  • Repka MA, Majumdar S, Kumar Battu S, et al. Applications of hot-melt extrusion for drug delivery. Expert Opin Drug Deliv. 2008;5(12):1357–1376.
  • Liu J, Zhang F, McGinity JW. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur J Pharm Biopharm. 2001;52(2):181–190.
  • Patil H, Tiwari RV, Upadhye SB, et al. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Int J Pharm. 2015. DOI:10.1016/j.ijpharm.2015.04.009.
  • Repka MA, Gerding TG, Repka SL, et al. Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev Ind Pharm. 1999;25(5):625–633.
  • Repka MA, ElSohly MA, Munjal M, et al. Temperature stability and bioadhesive properties of delta9-tetrahydrocannabinol incorporated hydroxypropylcellulose polymer matrix systems. Drug Dev Ind Pharm. 2006;32(1):21–32.
  • Palem CR, Kumar Battu S, Maddineni S, et al. Oral transmucosal delivery of domperidone from immediate release films produced via hot-melt extrusion technology. Pharm Dev Technol. 2013;18(1):186–195.
  • Mididoddi PK, Repka MA. Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm. 2007;66(1):95–105.
  • Ghalanbor Z, Korber M, Bodmeier R. Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion. Pharm Res. 2010;27(2):371–379.
  • Patil H, Feng X, Ye X, et al. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach. Aaps J. 2015;17(1):194–205.
  • Patil H, Kulkarni V, Majumdar S, et al. Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion. Int J Pharm. 2014;471(1–2):153–156.
  • Ye X, Patil H, Feng X, et al. Conjugation of hot-melt extrusion with high-pressure homogenization: a novel method of continuously preparing nanocrystal solid dispersions. AAPS PharmSciTech. 2015. DOI:10.1208/s12249-015-0389-7.
  • Khinast J, Baumgartner R, Roblegg E. Nano-extrusion: a one-step process for manufacturing of solid nanoparticle formulations directly from the liquid phase. AAPS PharmSciTech. 2013;14(2):601–604.
  • Patterson JE, James MB, Forster AH, et al. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm. 2007;336(1):22–34.
  • Linn M, Collnot EM, Djuric D, et al. Soluplus(R) as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci. 2012;45(3):336–343.
  • Maddineni S, Battu SK, Morott J, et al. Influence of process and formulation parameters on dissolution and stability characteristics of Kollidon(R) VA 64 hot-melt extrudates. AAPS PharmSciTech. 2015;16(2):444–454.
  • Food and Drug Administration, Best Pharmaceuticals for Children Act (BPCA). 2007. Public Law; 2013. p. 107–109. [cited 2015 Sep 4]. Available from: http://bpca.nichd.nih.gov/about/Pages/Index.aspx
  • Maniruzzaman M, Boateng JS, Chowdhry BZ, et al. A review on the taste masking of bitter APIs: hot-melt extrusion (HME) evaluation. Drug Dev Ind Pharm. 2014;40(2):145–156.
  • Petereit HU, Meier C, Gryczke A Melt extrusion of salts of active ingredients. US8642089 B2. 2014.
  • Pimparade MB, Morott JT, Park JB, et al. Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluations. Int J Pharm. 2015;487(1–2):167–176.
  • Kumar CS. Nanotechnology tools in pharmaceutical R&D. Materials Today. 2010;12:24–30.
  • Miller DA, DiNunzio JC, Yang W, et al. Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption. Pharm Res. 2008;25(6):1450–1459.
  • Cassidy CM, Tunney MM, Caldwell DL, et al. Development of novel oral formulations prepared via hot melt extrusion for targeted delivery of photosensitizer to the colon. Photochem Photobiol. 2011;87(4):867–876.
  • Sax G, Winter G. Mechanistic studies on the release of lysozyme from twin-screw extruded lipid implants. J Control Release. 2012;163(2):187–194.
  • Park JB, Prodduturi S, Morott J, et al. Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology. Expert Opin Drug Deliv. 2015;12(1):1–13.
  • Webster L. Update on abuse-resistant and abuse-deterrent approaches to opioid formulations. Pain Med. 2009;10(Suppl 2):S124–S133.
  • Hemmingsen PH, Rex Olsen M. Injection molding and hot‐melt extrusion processing for pharmaceutical materials. In: Douroumis D, editor. Hot-melt extrusion: pharmaceutical applications. Chichester: John Wiley & Sons Ltd; 2012. p. 239–259.
  • Approved drug products with therapeutic equivalance evaluations. 35th ed. Cumulative supllement 8. 2015 Aug [cited 2015 Sep 4]. Available from: http://www.fda.gov/downloads/drugs/informationondrugs/ucm086233.pdf
  • Upadhye SB, Rajabi-Siahboomi AR. Properties and applications of polyethylene oxide and ethylcellulose for tamper resistance and controlled drug delivery. In: Repka MA, Langley N, DiNunzio J, editors. Melt extrusion. New York (NY): Springer; 2013. p. 145–158.
  • Johannes Bartholomäus JA, Stahlberg H-J, Galia E, et al. Innovative formulation technology protecting intended drug action. Drug Dev Deliv. 2012;12(8):1–6.
  • Bartholomaeus JH, Arkenau-Maric E, Galia E. Opioid extended-release tablets with improved tamper-resistant properties. Expert Opin Drug Deliv. 2012;9(8):879–891.
  • Maddineni S, Battu SK, Morott J, et al. Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments. J Pharm Pharmacol. 2014;66(2):309–322.
  • Vynckier AK, Dierickx L, Voorspoels J, et al. Hot-melt co-extrusion: requirements, challenges and opportunities for pharmaceutical applications. J Pharm Pharmacol. 2014;66(2):167–179.
  • Dierickx L, Saerens L, Almeida A, et al. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices. Eur J Pharm Biopharm. 2012;81(3):683–689.
  • Dierickx L, Van Snick B, Monteyne T, et al. Co-extruded solid solutions as immediate release fixed-dose combinations. Eur J Pharm Biopharm. 2014;88(2):502–509.
  • Ursan ID, Chiu L, Pierce A. Three-dimensional drug printing: a structured review. J Am Pharm Assoc. 2013;53:136–144.
  • Preis M, Breitkreutz J, Sandler N. Perspective: concepts of printing technologies for oral film formulations. Int J Pharm. 2015;494(2):578–584.
  • Ventola CL. Medical applications for 3D printing: current and projected uses. Pharm Ther. 2014;39(10):704–711.
  • Goyanes A, Buanz AB, Basit AW, et al. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 2014;476(1–2):88–92.
  • Pietrzak K, Isreb A, Alhnan MA. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm. 2015;96:380–387.
  • Liu X, Lu M, Guo Z, et al. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion. Pharm Res. 2012;29(3):806–817.
  • Dhumal RS, Kelly AL, York P, et al. Cocrystalization and simultaneous agglomeration using hot melt extrusion. Pharm Res. 2010;27(12):2725–2733.
  • Daurio D, Medina C, Saw R, et al. Application of twin screw extrusion in the manufacture of cocrystals, part I: four case studies. Pharmaceutics. 2011;3(3):582–600.
  • Moradiya H, Islam MT, Woollam GR, et al. Continuous cocrystallization for dissolution rate optimization of a poorly water-soluble drug. Cryst Growth Des. 2013;14(1):189–198.
  • Lakshman JP, Cao Y, Kowalski J, et al. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol Pharm. 2008;5(6):994–1002.
  • Lakshman JP. Formulation, bioavailability, and manufacturing process enhancement: novel applications of melt extrusion in enabling product development. In: Repka MA, Langley N, DiNunzio J, editors. Melt extrusion. New York (NY): Springer; 2013. p. 329–362.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.